Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Microbiology|July 9, 2021
Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus VaccineVincent Jean-Pierre, Julien Lupo, Marlyse Buisson, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2026
Molecular basis of linezolid resistance in Finegoldia spp. from orthopedic infectionsVincent Jean-Pierre, Mikeldi Moulieras, Alix Pantel, et al.
International Journal of Molecular Sciences|January 8, 2023
Biofilm Formation by Staphylococcus aureus in the Specific Context of Cystic FibrosisVincent Jean-Pierre, Agathe Boudet, Pauline Sorlin, et al.
Annals of Clinical Microbiology and Antimicrobials|August 22, 2024
Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genusVincent Jean-Pierre, Pauline Sorlin, Katy Jeannot, et al.
Annals of Clinical Microbiology and Antimicrobials|June 17, 2024
Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strainsVincent Jean-Pierre, Pauline Sorlin, Alix Pantel, et al.
Parasite (Paris, France)|November 9, 2022
Serological diagnosis of toxoplasmosis: evaluation of the commercial test recomLine Toxoplasma IgG immunoblot (Mikrogen) based on recombinant antigensVincent Jean-Pierre, Julien Miozzo, Hélène Fricker-Hidalgo, et al.
Biofilm|June 26, 2026
Early and mature Achromobacter xylosoxidans biofilm in cystic fibrosis and non-cystic fibrosis isolates: dynamics and response to clinically relevant antibioticsVincent Jean-Pierre, Pauline Sorlin, Catherine Dunyach-Remy, et al.
Annals of Clinical Microbiology and Antimicrobials|March 20, 2025
TROJAN-MDR: in vitro activity of cefiderocol and comparators against multidrug-resistant Enterobacterales and Pseudomonas aeruginosa strains in Southern France, evaluation of available testing methods performancesMassinissa Benyahia, Chloé Magnan, Vincent Jean-Pierre, et al.
Scientific Reports|July 2, 2025
Achromobacter xylosoxidans modulates Pseudomonas aeruginosa virulence through a complex multi-target competitionAlison Besse, Quentin Menetrey, Vincent Jean-Pierre, et al.
International Journal of Antimicrobial Agents|March 7, 2026
Minor non-fermenting Gram-negative bacilli in Europe, 2020-2024 (MINOFEu)Gabriele Bianco, Paulo Bastos, Konstantina Gartzonika, et al.
Pageof 2